Environmental Protection Agency (EPA) Completes Review of Seresto Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product - Seite 3

In-clinic veterinarians also continue to voice their support of Seresto as a convenient, dependable and affordable option for consumers.

“This conclusion from EPA comes at a critical time as pet owners need to be thinking about protecting their pets from pests during this heavy flea and tick season. As a veterinarian and pet owner myself, I know the importance of protecting both pets and humans from risks associated with fleas and ticks,” said Dr. Lisa Lippman, practicing veterinarian. “With the Seresto collar, the substantial body of scientific evidence continues to support its strong safety profile and effectiveness to provide eight continuous months of protection against fleas and ticks which can transmit dangerous diseases, such as Lyme disease. Seresto offers a much-needed, cost-effective option for protection. That’s why I fully support and use Seresto and recommend it to pet owners for usage year-round.”

Numerous studies and incident data analyses have concluded that Seresto has a strong safety profile and does not pose an unreasonable risk, which is why the American Veterinary Medical Association has expressed support for Seresto’s continued EPA registration.

ABOUT ELANCO

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching Life and our approach to sustainability, Elanco Healthy Purpose– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.

ⁱ Trends in Reported Babesiosis Cases — United States, 2011–2019 | MMWR (cdc.gov)

ⁱⁱ Companion Animal Parasite Council | 2023 Annual Pet Parasite Forecasts (capcvet.org)

View source version on businesswire.com: https://www.businesswire.com/news/home/20230713309283/en/

The Elanco Animal Health Stock at the time of publication of the news with a raise of +2,71 % to 10,60EUR on NYSE stock exchange (13. Juli 2023, 23:05 Uhr).